Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Pathogens (Basel, Switzerland)|January 21, 2023
Chlamydia Peritonitis Mimicking Juvenile Carcinomatous Peritonitis Diagnosed by Exploratory Laparoscopy: A Case ReportHaruka Nishida, Yuko Takahashi, Kohei Takehara, et al.
BMC Women'S Health|March 29, 2025
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case seriesHaruka Nishida, Kohei Takehara, Takako Onodera, et al.
Journal of Intensive Care|September 5, 2022
Association between ICU admission during off-hours and in-hospital mortality: a multicenter registry in JapanYu Namikata, Yoshinori Matsuoka, Jiro Ito, et al.
Journal of Ovarian Research|June 14, 2023
Serum vascular endothelial growth factor associated with the progression of granulosa cell tumor: a report of two casesKazuki Takasaki, Takayuki Ichinose, Yuko Miyagawa, et al.
Journal of Ovarian Research|August 24, 2024
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancerKazuki Takasaki, Takayuki Ichinose, Haruka Nishida, et al.
BMC Women'S Health|August 20, 2021
A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapyYukifumi Sasamori, Kohei Takehara, Tsuyoshi Terashima, et al.
Radiology Case Reports|August 9, 2021
CT, MRI, and FDG-PET imaging findings of low-grade extrauterine endometrial stromal sarcoma arising from the mesentery: A case reportSatoshi Suzuki, Ryo Kurokawa, Tetsushi Tsuruga, et al.
The Journal of Obstetrics and Gynaecology Research|August 25, 2020
Desensitization strategy for hypersensitivity reactions to carboplatin in five patients with gynecological cancerYusuke Toyohara, Kenbun Sone, Haruka Nishida, et al.
Cancer Science|April 1, 2021
Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancersKohei Yamaguchi, Yoko Matsumoto, Ryo Suzuki, et al.
Vaccine|September 27, 2014
Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patientsKei Kawana, Katsuyuki Adachi, Satoko Kojima, et al.
Pageof 5